Moberg Pharma's products are based on innovative drug delivery of proven compounds – a strategy which reduces time to market, development cost and risk. Moberg Pharma’s product families includes Emtrix®
for damaged nails (Nalox™ in Sweden), Kerasal®
for podiatric treatments, JointFlex®
for topical treatment of pain and Kaprolac®
for treatment of dandruff-related problems. The company is working on several additional pharmaceutical projects, including nail fungus (onychomycosis). In addition to internal inventions, the portfolio includes acquired and in-licensed products and projects.
To visit our U.S. company website, please click here